Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 May;13(5):4215-20.
doi: 10.3892/mmr.2016.5052. Epub 2016 Mar 28.

Ameliorating effect of luteolin on memory impairment in an Alzheimer's disease model

Affiliations

Ameliorating effect of luteolin on memory impairment in an Alzheimer's disease model

Huimin Wang et al. Mol Med Rep. 2016 May.

Abstract

Alzheimer's disease (AD) is one of the most prevalent neurodegenerative disorder. It is characterized by the formation of amyloid plaques and neurofibrillary tangles in the brain, the degeneration of cholinergic neurons and neuronal cell death. The present study aimed to investigate the effect of luteolin, a flavonoid compound, on memory impairment in a streptozotocin (STZ)‑induced Alzheimer's rat model. Morris water maze and probe tests were performed to examine the effect of luteolin treatment on cognition and memory. The effect of luteolin on CA1 pyramidal layer thickness was also examined. The results demonstrated that luteolin significantly ameliorated the spatial learning and memory impairment induced by STZ treatment. STZ significantly reduced the thickness of CA1 pyramidal layer and treatment of luteolin completely abolished the inhibitory effect of STZ. Our results suggest that luteolin has a potentially protective effect on learning defects and hippocampal structures in AD.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Effect of luteolin on (A) escape latency and (B) traveled distance of the streptozotocin (STZ)-induced Alzheimer's disease rat model. *P<0.05 vs. control, ^P<0.05 vs. STZ group.
Figure 2
Figure 2
Effect of luteolin on swimming speed of the Alzheimer's disease rat model. STZ, streptozotocin.
Figure 3
Figure 3
Effect of luteolin on performance in probe test of the Alzheimer's disease rat model. *P<0.05 vs. control, ^P<0.05 vs. streptozotocin (STZ) group.
Figure 4
Figure 4
Effect of luteolin on CA1 pyramidal layer thickness of the Alzheimer's disease rat model. *P<0.05 vs. control, ^P<0.05 vs. streptozotocin (STZ) group.

Similar articles

Cited by

References

    1. Zhu Z, Yan J, Jiang W, Yao XG, Chen J, Chen L, Li C, Hu L, Jiang H, Shen X. Arctigenin effectively ameliorates memory impairment in Alzheimer's disease model mice targeting both β-amyloid production and clearance. J Neurosci. 2013;33:13138–13149. doi: 10.1523/JNEUROSCI.4790-12.2013. - DOI - PMC - PubMed
    1. Terry RD, Masliah E, Salmon DP, Butters N, DeTeresa R, Hill R, Hansen LA, Katzman R. Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol. 1991;30:572–580. doi: 10.1002/ana.410300410. - DOI - PubMed
    1. Choi SM, Kim BC, Cho YH, Choi KH, Chang J, Park MS, Kim MK, Cho KH, Kim JK. Effects of flavonoid compounds on β-amyloid-peptide-induced neuronal death in cultured mouse cortical neurons. Chonnam Med J. 2014;50:45–51. doi: 10.4068/cmj.2014.50.2.45. - DOI - PMC - PubMed
    1. Marcus DL, Thomas C, Rodriguez C, Simberkoff K, Tsai JS, Strafaci JA, Freedman ML. Increased peroxidation and reduced antioxidant enzyme activity in Alzheimer's disease. Exp Neurol. 1998;150:40–44. doi: 10.1006/exnr.1997.6750. - DOI - PubMed
    1. Zheng L, Kågedal K, Dehvari N, Benedikz E, Cowburn R, Marcusson J, Terman A. Oxidative stress induces macroautophagy of amyloid beta-protein and ensuing apoptosis. Free Radic Biol Med. 2009;46:422–429. doi: 10.1016/j.freeradbiomed.2008.10.043. - DOI - PubMed